论文部分内容阅读
目的探讨并分析胺碘酮应用于临床治疗心病急性心肌梗死伴高危快速型心律失常的临床效果。方法随机抽取我院2014年6月-2016年6月收治的冠心病急性心肌梗死伴高危快速型心律失常的病例120例进行回顾性研究分析。将120例病例随机平均分为参照组和实验组两组。参照组的病例采用常规治疗方法 ;实验组则采用胺碘酮进行治疗,将两组的治疗结果进行比较分析。结果 60例实验组患者33例(55%)显效,24例(40%)有效,无效3例(5%),总有效率为95%。参照组60例患者24例(40%)显效,25例(41.7%)有效,11例(18.3%)无效,总有效率为81.7%。两组患者数据对比,差异显著,具备统计学意义。结论将胺碘酮运用到临床治疗冠心病急性心肌梗死伴高危快速型心律失常,既安全有效,又降低了并发症的发生率,临床效果非常显著,值得推广于临床使用。
Objective To investigate and analyze the clinical effect of amiodarone in clinical treatment of acute myocardial infarction with high-risk and rapid-onset arrhythmia. Methods A total of 120 cases of acute myocardial infarction with high-risk tachyarrhythmia in our hospital from June 2014 to June 2016 were randomly selected and analyzed retrospectively. 120 cases were randomly divided into two groups: reference group and experimental group. The reference group of patients with conventional treatment methods; experimental group was treated with amiodarone, the two groups of treatment results were compared. Results Sixty-three patients (55%) in the experimental group were effective, 24 (40%) were effective, 3 (5%) were ineffective and the total effective rate was 95%. Twenty-four patients (40%) in the reference group were effective, 25 (41.7%) were effective, 11 (18.3%) were ineffective, and the total effective rate was 81.7%. The two groups of patients data comparison, significant difference, with statistical significance. Conclusion The clinical application of amiodarone to clinical treatment of acute myocardial infarction with high-risk and rapid-onset arrhythmia is safe and effective, and the incidence of complications is reduced. The clinical effect is significant and worthy of promotion in clinical use.